Damora Therapeutics targets mutCALR in ET/MF with potent DMR-001 and CLARITY-101 timelines, funded into 2029. Read my analysis for more.

As consumers, we are constantly making choices about things like what to eat at a restaurant, what clothing to buy at a store ...

Despite the explosive growth of digital wallet applications in Nepal, the insurance services offered by these applications ...

Background Malaria distribution in sub-Saharan Africa is becoming increasingly spatially heterogeneous. Pre-elimination areas ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Once you decide on a loan amount and term, add a few more details to search for auto lenders that meet your criteria. You’ll also see their current interest rate ranges. The terms presented here are ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst for 20+ years. He is a Chartered Market Technician ...

Taylor Medine is a staff writer for Forbes Advisor with over 10 years of experience writing guides and articles that demystify personal finance topics, such as how to repay debt, build credit and ...

Artificial intelligence-related stocks continue to draw investors hoping the second quarter’s massive gains will continue, even as providing continued strong returns could be a challenge. “AI stocks ...